ceftazidime

This page shows the latest ceftazidime news and features for those working in and with pharma, biotech and healthcare.

Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought

Originally developed by Actavis (which was acquired by Allergan in a $25bn deal in 2014), Avycaz combines established cephalosporin antibiotic ceftazidime with avibactam, a novel beta lactamase inhibitor that helps tackle

Latest news

Pfizer launches new antibiotic Zavicefta in UK and Germany

The European Medicines Agency (EMA) cleared Zavicefta (ceftazidime and avibactam) for the treatment of complicated Gram-negative bacterial infections requiring hospitalisation last year.
AZ slims down again with sale of antibiotics to Pfizer

The deal includes the approved antibiotics Merrem (meropenem), Zinforo (ceftaroline fosamil) and just-licensed Zavicefta (ceftazidime/avibactam), as well as two injectable antibiotic candidates - Allergan-partnered ATM-AVI (aztreonam/avibactam) and
AZ gets EU green light for new antibiotic Zavicefta

The European Medicines Agency (EMA) cleared Zavicefta (ceftazidime and avibactam) for the treatment of serious Gram-negative bacterial infections requiring hospitalization.
Merck starts pivotal trials of new antibiotic combination

aeruginosa. AstraZeneca (AZ) recently secured CHMP backing in Europe for Zavicefta - which combines established cephalosporin antibiotic ceftazidime with new-generation beta lactamase inhibitor avibactam.
CHMP backs AZ's 'superbug' antibiotic product

The Committee for Medicinal Products for Human Use (CHMP) recommended approval of Zavicefta (ceftazidime/avibactam), which combines an established antibiotic with a new drug designed to overcome bacterial resistance. ... In the US, Actavis (now operating

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest Intelligence

Deal Watch August 2016

14, 000. AstraZeneca (UK) antibiotic business. Pfizer (US). Asset acquisition. EU approved ceftazidime-avibactam), marketed meropenem and ceftaroline fosamil and clinical development assets aztreonam-avibactam (ATM-AVI) and CXL.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Associate Scientific Director: Salary TBC

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Graduate Scientific Editor: DOE

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Account Manager- 4 days per week or full-time: Salary TBC

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Senior Account Manager – Healthcare Advertising: Salary TBC

Healthcare PR Senior Account Manager: Salary TBC

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Senior Medical Writer: Salary is DOE

Senior Training Manager - Surrey: Competitive Salary &Bonus

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Writer, Healthcare Advertising, London: Excellent package

Senior Medical Writer, MedComms Agency: Salary TBC

Medical Writer - Creative and Scientific Projects: DOE

Account Director, Healthcare Advertising Agency: Salary TBC

Editorial Director – Medical Education: Neg

Account Director or Senior Account Director: Salary TBC

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....